Form 4: Third Harmonic Bio Chief Medical Officer Receives Stock Options and Restricted Stock Units

Third Harmonic Bio's Chief Medical Officer, Edward R. Conner, was granted stock options and restricted stock units as part of the company's annual refresh equity grant process.

Summary

• Edward R. Conner, the Chief Medical Officer of Third Harmonic Bio, received equity awards on January 15, 2025.
• These awards include stock options for 132,000 shares and 16,500 restricted stock units (RSUs).
• The stock options have an exercise price of $6 and vest monthly over four years, starting February 15, 2025.
• The RSUs vest annually over four years, starting February 15, 2026.
• The equity awards were approved by the board of directors on December 17, 2024, as part of the annual refresh equity grant process.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation, which is generally positive for aligning management and shareholder interests. There are no negative implications.

Positives

• The equity grants align the Chief Medical Officer's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.
• The grants are part of a regular annual process, indicating a consistent approach to executive compensation.

Industry Context

Equity grants are a common practice in the biotechnology industry to attract and retain key executives.

Comparison to Industry Standards

• Equity grants are a standard form of compensation for executives in the biotech industry, often including a mix of stock options and restricted stock units.
• The vesting schedules described are typical for these types of grants, designed to incentivize long-term performance and retention.
• The specific amounts and terms of the grants would need to be compared to similar companies to determine if they are in line with industry norms.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align management's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership team.

Key Dates

Keywords

stock options, restricted stock units, equity awards, executive compensation, insider trading, Form 4, Third Harmonic Bio, THRD